Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G

Kristina Borochova1, Katarzyna Niespodziana1, Katarina Stenberg Hammar2,3,4

  • 1Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.

Vaccines
|July 8, 2020
PubMed

Insights

Respiratory syncytial virus (RSV) glycoprotein G is a key target for protective antibodies. This study reveals G-specific IgG responses in adults and children, highlighting G

Area of Science:

  • Immunology
  • Virology
  • Vaccine Development

Background:

  • Respiratory syncytial virus (RSV) causes severe infant respiratory illness.
  • RSV subgroups A and B differ in their surface glycoprotein G.
  • The G protein is crucial for viral attachment and elicits protective antibodies.

Purpose of the Study:

  • To investigate the natural IgG antibody response to RSV glycoprotein G.
  • To assess the role of G protein in RSV infection and vaccine development.

Main Methods:

  • Expression of the surface-exposed part of RSV G protein (A2-G).
  • Synthesis of overlapping peptides spanning A2-G.
  • Analysis of natural IgG response in adult sera over one year.
  • Investigation of IgG subclass reactivity and neutralizing antibody levels.

Main Results:

  • IgG antibodies recognized G protein significantly more strongly than fusion protein F0.
  • Antibodies targeted sequential and buried peptide epitopes on G protein.
  • A mixed Th1/Th2 response was indicated by IgG subclass profiles.
  • High IgG anti-G levels were found in neutralizing sera.
  • G-specific IgG increased in children post-wheezing, suggesting RSV as a trigger.

Conclusions:

  • RSV G protein and its peptides are valuable for diagnosing RSV-triggered respiratory exacerbations.
  • The G protein is a critical target for developing effective RSV-neutralizing vaccines.

Related Concept Videos

Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
64.9K
Antibody Structure and Classes01:25

Antibody Structure and Classes

Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
7.9K
Cross-reactivity00:42

Cross-reactivity

Overview
32.6K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.5K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
82.8K